MEGESTROL-ACETATE

被引：37

作者：

CANETTA, R ^{[1
]}

FLORENTINE, S ^{[1
]}

HUNTER, H ^{[1
]}

LENAZ, L ^{[1
]}

机构：

[1] MEAD JOHNSON & CO,DIV PHARMACEUT,EVANSVILLE,IN 47721

来源：

关键词：

D O I：

10.1016/0305-7372(83)90029-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：141 / 157

页数：17

共 102 条

[1] THE USE OF ESTROGENS AND ANDROGENS IN ADVANCED MAMMARY CANCER - CLINICAL AND LABORATORY STUDY OF 105 FEMALE PATIENTS
ADAIR, FE
MELLORS, RC
FARROW, JH
WOODARD, HQ
ESCHER, GC
URBAN, JA
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1949, 140 (15): : 1193 - 1200
[2] MASS FRAGMENTOGRAPHIC METHOD FOR DETERMINATION OF MEGESTROL ACETATE IN PLASMA AND ITS APPLICATION TO STUDIES ON PLASMA-LEVELS AFTER ADMINISTRATION OF PROGESTIN TO PATIENTS WITH CARCINOMA-CORPORIS-UTERI
ADLERCREUTZ, H
NIEMINEN, U
ERVAST, HS
[J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1974, 5 (07) : 619 - 626
[3] ALEXIEVAFIGUSCH.J, 1980, CANCER, V46, P2396
[4] ESTROGEN-RECEPTOR STATUS - IMPORTANT VARIABLE IN PREDICTING RESPONSE TO ENDOCRINE THERAPY IN METASTATIC BREAST-CANCER
ALLEGRA, JC
LIPPMAN, ME
THOMPSON, EB
SIMON, R
BARLOCK, A
GREEN, L
HUFF, KK
DO, HMT
AITKEN, SC
WARREN, R
[J]. EUROPEAN JOURNAL OF CANCER, 1980, 16 (03) : 323 - 331
[5] ANSFIELD FJ, 1974, CANCER, V33, P907, DOI 10.1002/1097-0142(197404)33:4<907::AID-CNCR2820330403>3.0.CO
[6] 2-Y
[7] ANSFIELD FJ, 1976, CANCER, V38, P53, DOI 10.1002/1097-0142(197607)38:1<53::AID-CNCR2820380110>3.0.CO
[8] 2-C
[9] MEGACE AND NO DIABETES-MELLITUS
ANSFIELD, FJ
[J]. ANNALS OF INTERNAL MEDICINE, 1977, 86 (03) : 365 - 365
[10] ARENDS J, 1963, ARCH PHARM CHEMI, V70, P907